"Inflammasome inhibitors as new first-in-class anti-inflammatory therapies”
2022 NHMRC Investigator Grant
Inflammation drives many devastating human diseases, and there are currently no effective treatments for many such diseases.
Kate's research program aims to leverage her validated discovery and development pipeline to deliver new first-in-class anti-inflammatory drugs to treat devastating diseases such as chronic liver disease and inflammatory bowel disease.
Copyright © 2017 - The University of Queensland